Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Calabresi

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Annals of Medicine|November 16, 2019
HDL therapy today: from atherosclerosis, to stent compatibility to heart failureC R Sirtori, M Ruscica, L Calabresi, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|April 1, 1993
Increased postprandial lipemia in Apo A-IMilano carriersL Calabresi, M Cassinotti, G Gianfranceschi, et al.
Metabolism: Clinical and Experimental|August 1, 1988
Alterations in the HDL system after rapid plasma cholesterol reduction by LDL-apheresisG Franceschini, P Apebe, L Calabresi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 14, 1999
Increased cholesterol efflux potential of sera from ApoA-IMilano carriers and transgenic miceG Franceschini, L Calabresi, G Chiesa, et al.
Stroke|August 1, 1994
Apolipoprotein E epsilon 4 allele frequency in vascular dementia and Alzheimer's diseaseG B Frisoni, C Geroldi, A Bianchetti, et al.
Annals of Neurology|May 1, 1995
Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's diseaseG B Frisoni, S Govoni, C Geroldi, et al.
British Journal of Pharmacology|April 1, 2011
The thienotriazolodiazepine Ro 11-1464 increases plasma apoA-I and promotes reverse cholesterol transport in human apoA-I transgenic miceI Zanotti, C Maugeais, M Pedrelli, et al.
Clinical and Experimental Rheumatology|May 1, 1995
Lipid profile and anticardiolipin antibodies in rheumatoid arthritisB Seriolo, D Fasciolo, S Accardo, et al.
Biochemical and Biophysical Research Communications|September 23, 1997
Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteinsL Calabresi, G Franceschini, C R Sirtori, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 24, 2001
L-carnitine reduces plasma lipoprotein(a) levels in patients with hyper Lp(a)C R Sirtori, L Calabresi, S Ferrara, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Annals of Medicine|November 16, 2019
HDL therapy today: from atherosclerosis, to stent compatibility to heart failureC R Sirtori, M Ruscica, L Calabresi, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|April 1, 1993
Increased postprandial lipemia in Apo A-IMilano carriersL Calabresi, M Cassinotti, G Gianfranceschi, et al.
Metabolism: Clinical and Experimental|August 1, 1988
Alterations in the HDL system after rapid plasma cholesterol reduction by LDL-apheresisG Franceschini, P Apebe, L Calabresi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 14, 1999
Increased cholesterol efflux potential of sera from ApoA-IMilano carriers and transgenic miceG Franceschini, L Calabresi, G Chiesa, et al.
Stroke|August 1, 1994
Apolipoprotein E epsilon 4 allele frequency in vascular dementia and Alzheimer's diseaseG B Frisoni, C Geroldi, A Bianchetti, et al.
Annals of Neurology|May 1, 1995
Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's diseaseG B Frisoni, S Govoni, C Geroldi, et al.
British Journal of Pharmacology|April 1, 2011
The thienotriazolodiazepine Ro 11-1464 increases plasma apoA-I and promotes reverse cholesterol transport in human apoA-I transgenic miceI Zanotti, C Maugeais, M Pedrelli, et al.
Clinical and Experimental Rheumatology|May 1, 1995
Lipid profile and anticardiolipin antibodies in rheumatoid arthritisB Seriolo, D Fasciolo, S Accardo, et al.
Biochemical and Biophysical Research Communications|September 23, 1997
Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteinsL Calabresi, G Franceschini, C R Sirtori, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 24, 2001
L-carnitine reduces plasma lipoprotein(a) levels in patients with hyper Lp(a)C R Sirtori, L Calabresi, S Ferrara, et al.
Pageof 7